H.R. 830

119th Congress

In Committee

SAFE Act

Sponsored byDemocrat:Rep. Pappas, Chris [D-NH-1]NH· Introduced 31 janvier 2025

17

Cosponsors

4

Actions

0

Amendments

2

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

31 janvier 2025·1 year ago

Summary

Introduced in House · Updated 26 septembre 2025

Save Americans from the Fentanyl Emergency Act or the SAFE Act

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires on March 31, 2025.

It limits mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows federal courts to vacate or reduce sentences for convictions involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II.

The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.

Timeline

4 actions

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    31 janvier 2025 · IntroReferral

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    31 janvier 2025 · IntroReferral

  3. Introduced in House

    31 janvier 2025 · IntroReferral

  4. Introduced in House

    31 janvier 2025 · IntroReferral

Sponsorship

17 cosponsors

Sponsor

Democrat:Rep. Pappas, Chris [D-NH-1]NH

Cosponsors

  • Democrat1482%
  • Republican318%

Classification

Policy area

Crime and Law Enforcement

Legislative subjects

Administrative law and regulatory proceduresCongressional oversightCriminal procedure and sentencingDepartment of JusticeDrug trafficking and controlled substancesGovernment studies and investigationsInternational law and treatiesLicensing and registrationsManufacturingResearch administration and funding

Committees

2

  • Energy and Commerce Committee

    House · Standing

    • Referred To31 Jan 2025
  • Judiciary Committee

    House · Standing

    • Referred To31 Jan 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 2 on 31 janvier 2025 to 17 on 17 novembre 2025.

Pelosi Tracker
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.